Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients - Wikidata - awgldk - TriplyDB

Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients

Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients

http://www.wikidata.org/entity/Q33787621

about

Portal hypertension as immune mediate disease.Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease Elevated nitric oxide and 3',5' cyclic guanosine monophosphate levels in patients with alcoholic cirrhosis.Nitric oxide levels in chronic liver disease patients with and without oesophageal varices Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites Acute-on-chronic liver failure: a review.Acute-on-chronic liver failure: recent update.Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis?Upregulation of toll-like receptor 4 on T cells in PBMCs is associated with disease aggravation of HBV-related acute-on-chronic liver failure.

P2860

Q35197361-3D77A821-0CC4-4002-9586-38EF8BC083D0 Q35638789-D990DA4C-B22A-45A9-A216-B6E43A80F9D5 Q37174153-E6B7E6AC-4AD0-435D-86BF-8789B65C4B22 Q37278258-7BFB829B-0129-4635-9438-100DE09BAC69 Q37290831-978F4131-8080-4B6D-8671-1922D77C8ABA Q37729728-E5B3F93E-9BE3-4420-A57D-E70117E85ED4 Q38698971-46393892-BDA1-4692-B56C-1F743E9D9EE0 Q39204916-7E927AF3-726F-40E8-AC25-D333EE036B32 Q40870148-4FC61CA7-D27E-4D1F-A4E9-1D2989223B65

P2860

Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients

http://www.wikidata.org/entity/Q33787621

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Serum levels of soluble Fas, n ...... compensated cirrhotic patients

@ast

Serum levels of soluble Fas, n ...... compensated cirrhotic patients

@en

type

label

Serum levels of soluble Fas, n ...... compensated cirrhotic patients

@ast

Serum levels of soluble Fas, n ...... compensated cirrhotic patients

@en

prefLabel

Serum levels of soluble Fas, n ...... compensated cirrhotic patients

@ast

Serum levels of soluble Fas, n ...... compensated cirrhotic patients

@en

P1433

Q33787621-1FFF4265-E606-46EA-A1B8-510498059910

P1476

Q33787621-7BE09EA1-BD48-4948-B08B-BE6C9BDF8B49

P2093

Q33787621-1B1DD878-79FD-4A25-B66C-96D8D31AF14D

Q33787621-21FFD6E5-9D28-48D5-B104-23494D10A5DB

Q33787621-7B8BD347-E497-41A4-BDE6-95A00A06903D

P2860

Q33787621-0CAAD53F-713E-4C8B-84CE-DBE7A94E5803

Q33787621-31D1E5F5-BE0C-4277-8D56-F5C9AF316152

Q33787621-4EE92DB6-89DD-44F4-9007-9B98BA0CD991

Q33787621-62D8A051-5678-4039-BD14-C814B05D4139

Q33787621-641CFD55-C24C-40F3-B465-0A1FB4C321C3

Q33787621-71B50EC3-140D-420F-9D02-0FD6A2EF12BC

Q33787621-79F27B74-B129-455F-B70A-28403DF500A8

Q33787621-A9077FF0-544A-4C2C-95BA-620CA674678C

Q33787621-AFFFA2F4-0249-46FA-AF72-BB731710ADB5

Q33787621-BF21AA30-2DFF-420A-B660-386168447524

P304

Q33787621-3989CD6D-EDCC-49FF-8458-CD8898B63DB6

P31

Q33787621-5041B1CC-6622-497A-9DC4-200AF092B62A

P356

Q33787621-7A133C32-4C21-4CD9-9FB2-DB39B7E60D50

P407

Q33787621-B8B165B4-08F9-48D6-9506-90DEFFE3D132

P433

Q33787621-A2829DFC-B63C-49F2-83EE-9B1E48957BB0

P478

Q33787621-3DAB76A7-3CD8-4092-AE55-24AF12A6912B

P50

Q33787621-F5503685-58C4-4B43-9482-44EE0F5BEB08

P577

Q33787621-651804F8-6662-4914-ADC5-44C58105381F

P698

Q33787621-4E09AB11-2C1D-4962-8C16-5FDFDDBBA4AE

P932

Q33787621-18955575-3DBB-489A-8393-02CB791DD76F

P356

P1433

World Journal of Gastroenterology

P1476

Serum levels of soluble Fas, n ...... compensated cirrhotic patients

@en

P2093

Christoph Elsing

http://www.w3.org/2001/XMLSchema#string

Sabine Harenberg

http://www.w3.org/2001/XMLSchema#string

Thomas Herrmann

http://www.w3.org/2001/XMLSchema#string

P2860

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

Primary prophylaxis of variceal hemorrhage.

Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.

Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.

Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus.

The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension.

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing.

Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis.

Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.

Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.

P304

421-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V13.I3.421

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17230612

http://www.w3.org/2001/XMLSchema#string

P932

4065898

http://www.w3.org/2001/XMLSchema#string